IP Library Granted Patent US 9,279,769
Granted Patent B2
US 9,279,769 · App. 13/992,540 · Granted Mar 8, 2016

Proteins that efficiently generate singlet oxygen

Inventors: Xiaokun Shu (San Diego, CA); Roger Y. Tsien (La Jolla, CA)
Assignee: The Regents of the University of California
G01N21/6486C07K14/001C12N9/12C12Y207/11001C07K2319/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,279,769
App. No.
13/992,540
Granted
Mar 8, 2016
Kind
B2
Abstract

The present invention provides miniSOG proteins, polynucleotides, and methods of use. When expressed in a bacterial or mammalian cell, miniSOG proteins spontaneously incorporate flavin mononucleotide and produce fluorescence and singlet oxygen upon excitation. Uses include optical and electron microscope imaging, in vivo imaging, detection and localization of protein-protein interactions, and photoablation.

Claims (14)

1. An isolated polynucleotide encoding a miniSOG polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:1 and SEQ ID NO:2.

2. The isolated polynucleotide of claim 1 , wherein the miniSOG comprises an amino acid sequence of SEQ ID NO:1.

3. The isolated polynucleotide of claim 1 , wherein the miniSOG polypeptide consists of 106 amino acids.

4. The isolated polynucleotide of claim 1 , wherein the miniSOG polypeptide has a singlet oxygen quantum yield of 0.47±0.05 or more when bound to a flavin mononucleotide.

5. The isolated polynucleotide of claim 1 , wherein the polynucleotide encoding the miniSOG polypeptide is codon optimized for expression in E. coli or a eukaryotic cell.

6. The isolated polynucleotide of claim 5 , wherein the eukaryotic cell is a mammalian cell.

7. The isolated polynucleotide of claim 5 , wherein the mammalian cell is a human cell.

8. A vector comprising the polynucleotide sequence of claim 1 .

9. A host cell comprising the vector of claim 8 .

10. A miniSOG polypeptide encoded by the polynucleotide of claim 1 .

11. A kit comprising the polynucleotide of claim 1 .

12. A fusion protein comprising a polypeptide encoded by the polynucleotide of claim 1 .

13. A method of expressing in a cell a fusion protein, the method comprising the step of: expressing in a cell a fusion protein comprising i)a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:1 and SEQ ID NO:2 and ii) a protein if interest.

14. The isolated polynucleotide of claim 1 , wherein the miniSOG comprises an amino acid sequence of SEQ ID NO:2.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2016
From: SHU, XIAOKUN; TSIEN, ROGER Y.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 037430/0760 →
CONFIRMATORY LICENSE Recorded Oct 30, 2013
From: UNIVERSITY OF CALIFORNIA SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031514/0964 →
Continuity (2)
Provisional Application 61420719 · Dec 7, 2010
Related Publication 20130330718A1 · Dec 12, 2013